McKesson Corporation

MCK
Delayed Nyse - 04/25 10:02:06 pm
115.21USD
-0.1%
Prev.115.3300
Open115.0800
High115.9000
Low113.6900
Volume652 374
Financials
Sales 2019 215 B
EBIT 2019 3 565 M
R. net 2019 1 316 M
Debt 2019 5 252 M
Rend. 2019 1,27%
P/E ratio 2019 16,44
P/E ratio 2020 10,29
EV / Sales 2019 0,13x
EV / Sales 2020 0,12x
Capitalization 22 100 M
Company
McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows:
- distribution of pharmaceutical products (96.7%);
- distribution of medical and surgical products (3.2%);
-...
Sector :
Drug Retailers - NEC
Calendar :
2019-05-08 Earnings Release
Trading Rating :
Investor Rating :
Latest news
04/24MCKESSON : Declares Quarterly Dividend April 24, 2019
BU
04/23U.S. brings first criminal case against major drug distributor over opioids
RE
04/22MCKESSON : Delivering Better Care with the Right Products
PU
04/16MCKESSON : Kirk Kaminsky to Lead McKesson's U.S.-Based Pharmaceutical Business
AQ
04/15MCKESSON : Kirk Kaminsky to Lead McKesson's U.S.-Based Pharmaceutical Business
BU
04/15MCKESSON : 4 Ways Your Biopharmaceutical Company Can Improve Patient Outcomes
PU
04/10MCKESSON CORPORATION : to Hold Fiscal 2019 Fourth Quarter Conference Call and Participate in the Bank of America Merrill Lynch Health Care Conference
BU
04/10MCKESSON : Announces Move to Google Cloud
AQ
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishNeutralNeutral
Resistance117136150
Spread/Res.-1,7%-15%-23%
Spread/Supp.2,4%6,4%6,3%
Support112108108